{"id":2282,"date":"2017-12-06T15:53:00","date_gmt":"2017-12-06T06:53:00","guid":{"rendered":"http:\/\/web.brc.riken.jp\/ja\/?page_id=2282"},"modified":"2026-04-24T10:38:32","modified_gmt":"2026-04-24T01:38:32","slug":"link","status":"publish","type":"page","link":"http:\/\/web.brc.riken.jp\/en\/method\/link","title":{"rendered":"Licenses for Research Tools"},"content":{"rendered":"  <section class=\"chapter\">\r\n    <h4 class=\"middleheading\">Bioresources and Technologies licensed from other organizations<\/h4>\r\n<!-- \u65b0\u898f\u7de0\u7d50\u306e\u3082\u306e\u30fb\u6761\u4ef6\u304c\u5927\u304d\u304f\u5909\u66f4\u306b\u306a\u3063\u305f\u3082\u306e \u304c\u4e0a\u306b\u6765\u308b\u3088\u3046\u306b\u4e26\u3079\u308b -->\r\n    <ul class=\"OtherLinkList\">\r\n    <li>\r\n      <span class=\"logo\"><\/span>\r\n      <span class=\"explanation\">\r\n      <a href=\"https:\/\/web.brc.riken.jp\/en\/method\/link\/tbusa_conclude\">Notice about the license agreement between Takara Bio USA, Inc. and RIKEN BRC on preservation and distribution of Fluorescent Proteins for academic use<\/a>\r\n      <\/span>\r\n    <\/li>\r\n    <li>\r\n      <span class=\"logo\"><a href=\"https:\/\/www.igbmc.fr\/en\/igbmc\" rel=\"noopener noreferrer\">GIE-CERBM<br>(Centre Europeen De Recherche <br>En Biologie Et Medicine)<\/a><\/span>\r\n      <span class=\"explanation\"><a href=\"https:\/\/web.brc.riken.jp\/en\/method\/link\/gie_cerbm\">Regarding the deposit and distribution of bioresources containing Cre-ERT(2)<\/a><\/span>\r\n    <\/li>\r\n    <li>\r\n      <span class=\"logo\"><a href=\"https:\/\/www.herabiolabs.com\/\" rel=\"noopener noreferrer\">Hera BioLabs<\/a><\/span>\r\n      <span class=\"explanation\">\r\n        <a href=\"https:\/\/web.brc.riken.jp\/en\/method\/link\/hera_biolabs\">Hera BioLabs Inc. has permitted RIKEN BRC to collect, preserve and distribute the biological materials containing piggyBac(R) transposon<\/a>\r\n      <\/span>\r\n    <\/li>\r\n    <li>\r\n      <span class=\"logo\"><a target=\"_blank\" href=\"https:\/\/www.lifetechnologies.com\/\" rel=\"noopener noreferrer\">Life Technologies<\/a><\/span>\r\n      <span class=\"explanation\">\r\n        <a target=\"_blank\" href=\"https:\/\/brc.riken.jp\/dna\/frmegtwy\" rel=\"noopener noreferrer\">Life Technologies Corporation signs license agreement with RIKEN BRC<\/a>\r\n      <\/span>\r\n    <\/li>\r\n    <li>\r\n      <span class=\"logo\">Broad Institute<br\/>of MIT and Harvard<\/span>\r\n      <span class=\"explanation\">\r\n        <a href=\"https:\/\/web.brc.riken.jp\/en\/method\/link\/broad_institute\">Broad Institute has permitted RIKEN BRC to collect, preserve and distribute the genome edited bioresources using the CRISPR\/Cas9 technology<\/a>\r\n      <\/span>\r\n    <\/li>\r\n    <li>\r\n      <span class=\"logo\"><a target=\"_blank\" href=\"http:\/\/www.mbl.co.jp\/\" rel=\"noopener noreferrer\">\r\n        <img decoding=\"async\" src=\"https:\/\/web.brc.riken.jp\/ja\/wp-content\/uploads\/logo_MBL.png\" alt=\"MBL logo\" width=\"140px\" height=\"56px\" class=\"alignnone size-full wp-image-5810\" \/><\/a>\r\n      <\/span>\r\n      <span class=\"explanation\">\r\n        <a target=\"_blank\" href=\"\/en\/method\/link\/fucci\" rel=\"noopener noreferrer\">Announcement of modification of the terms and conditions for use of the Fucci mice<\/a><br>\r\n      <\/span>\r\n    <\/li>\r\n    <li>\r\n      <span class=\"logo\"><a target=\"_blank\" href=\"https:\/\/www.idpharma.jp\/\" rel=\"noopener noreferrer\">\r\n        <img decoding=\"async\" src=\"https:\/\/web.brc.riken.jp\/ja\/wp-content\/uploads\/logo_id_pharma.png\" alt=\"ID Pharma logo\" width=\"180px\" height=\"38px\" class=\"alignnone size-full\" \/><\/a>\r\n      <\/span>\r\n      <span class=\"explanation\">\r\n      <a href=\"https:\/\/web.brc.riken.jp\/en\/method\/link\/sendaivirus_vector\">iPS cells created using the Sendai virus vector are now available<\/a>\r\n      <\/span>\r\n    <\/li>\r\n    <li>\r\n      <span class=\"logo\"><a target=\"_blank\" href=\"http:\/\/www.tetsystems.com\/\" rel=\"noopener noreferrer\">\r\n        <img decoding=\"async\" src=\"https:\/\/web.brc.riken.jp\/ja\/wp-content\/uploads\/logo_TETsystem.png\" alt=\"TETsystem logo\" width=\"180px\" height=\"68px\" class=\"alignnone size-full wp-image-5811\" \/> <\/a>\r\n      <\/span>\r\n      <span class=\"explanation\">\r\n        <a href=\"https:\/\/web.brc.riken.jp\/en\/method\/link\/tet_system\" rel=\"noopener noreferrer\">Announcement of bioresources containing the tetracycline-inducible gene expression (TET) system<\/a>\r\n      <\/span>\r\n    <\/li>\r\n    <li>\r\n      <span class=\"logo\"><a href=\"https:\/\/www.cytivalifesciences.com\/en\/us\" rel=\"noopener noreferrer\">Cytiva<\/a><\/span>\r\n      <span class=\"explanation\">\r\n        <a href=\"https:\/\/web.brc.riken.jp\/en\/method\/link\/gfp_conclude\">Announcement of GFP bioresources<\/a>\r\n      <\/span>\r\n    <\/li>\r\n  <\/ul>\r\n<\/section>\r\n","protected":false},"excerpt":{"rendered":"Bioresources and Technologies licensed from other organizations Notice about the license agreement between Takara Bio USA, Inc. and RIKEN BRC on preservation and distribution of Fluorescent Proteins for academic use GIE-CERBM(Centre Europeen De Recherche En Biologie Et Medicine) Regarding the deposit and distribution of bioresources containing Cre-ERT(2) Hera BioLabs Hera BioLabs Inc. has permitted RIKEN BRC to collect, preserve and distribute the biological materials containing piggyBac(R) transposon Life Technologies Life Technologies Corporation signs license agreement with RIKEN BRC Broad Instituteof MIT and Harvard Broad Institute has permitted RIKEN BRC to collect, preserve and distribute the genome edited bioresources using the CRISPR\/Cas9 technology Announcement of modification of the terms and conditions &hellip; <p class=\"link-more\"><a href=\"http:\/\/web.brc.riken.jp\/en\/method\/link\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Licenses for Research Tools&#8221;<\/span><\/a><\/p>","protected":false},"author":12,"featured_media":0,"parent":5067,"menu_order":4,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"_seopress_robots_primary_cat":"","_seopress_titles_title":"","_seopress_titles_desc":"","_seopress_robots_index":"","footnotes":"","_wp_rev_ctl_limit":""},"class_list":["post-2282","page","type-page","status-publish","hentry","entry"],"acf":[],"_links":{"self":[{"href":"http:\/\/web.brc.riken.jp\/en\/wp-json\/wp\/v2\/pages\/2282","targetHints":{"allow":["GET"]}}],"collection":[{"href":"http:\/\/web.brc.riken.jp\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"http:\/\/web.brc.riken.jp\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"http:\/\/web.brc.riken.jp\/en\/wp-json\/wp\/v2\/users\/12"}],"replies":[{"embeddable":true,"href":"http:\/\/web.brc.riken.jp\/en\/wp-json\/wp\/v2\/comments?post=2282"}],"version-history":[{"count":22,"href":"http:\/\/web.brc.riken.jp\/en\/wp-json\/wp\/v2\/pages\/2282\/revisions"}],"predecessor-version":[{"id":11981,"href":"http:\/\/web.brc.riken.jp\/en\/wp-json\/wp\/v2\/pages\/2282\/revisions\/11981"}],"up":[{"embeddable":true,"href":"http:\/\/web.brc.riken.jp\/en\/wp-json\/wp\/v2\/pages\/5067"}],"wp:attachment":[{"href":"http:\/\/web.brc.riken.jp\/en\/wp-json\/wp\/v2\/media?parent=2282"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}